
Regulatory Considerations for Early-Stage Cell and Gene Therapies

Speaker Presentation CE Pharm 2024
Argus Elvira, HHS/FDA, 2024
Regulatory Considerations for Early-Stage Cell and Gene Therapies
Speaker Presentation CE Pharm 2024
Argus Elvira, HHS/FDA, 2024
Regulatory Considerations for Early-Stage Cell and Gene Therapies